Tivic Health Systems

Tivic Health Systems ROA

The Return on Assets (ROA) of Tivic Health Systems (TIVC) as of Nov 1, 2026 is -28.09 %. In the previous year, Return on Assets (ROA) was -201.46 % — a change of -86.06% (higher).

ROA

-28.09 %

YoY

-86.06%

Last updated:

In 2025, Tivic Health Systems's return on assets (ROA) was -28.09 %, a -86.06% increase from the -201.46 % ROA in the previous year.

The Tivic Health Systems ROA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROA
Date
ROA
Jan 1, 2019
-137.17 USD
Jan 1, 2020
-237.69 USD
Jan 1, 2021
-56.49 USD
Jan 1, 2022
-167.76 USD
Jan 1, 2023
-159.86 USD
Jan 1, 2024
-201.46 USD
Jan 1, 2025
-28.09 USD
The Tivic Health Systems ROA history
YEARROAYoY
-28.09 %-86.06%
-201.46 %+26.02%
-159.86 %-4.71%
-167.76 %+196.97%
-56.49 %-76.23%
-237.69 %+73.28%
-137.17 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Tivic Health Systems Stock analysis

What does Tivic Health Systems do? Tivic Health Systems Inc is a commercial-stage health tech company advancing bioelectronic medicine with patented technology that stimulates trigeminal, sympathetic, and vagus nerve structures. Its first commercial product, ClearUP, is an FDA-approved handheld bioelectronic sinus device clinically proven and doctor-recommended for treating inflammatory chronic conditions. ClearUP is sold directly to consumers in the U.S. through online retailers and commercial distributors, with reseller channels expanding its market reach. The company focuses on expanding its intellectual property portfolio and research programs related to vagus nerve stimulation for broader therapeutic applications. ClearUP serves consumers seeking drug-free therapeutic solutions for sinus conditions, targeting individuals with inflammatory chronic health issues who prefer non-invasive treatments. Healthcare providers recommend ClearUP as a safe, low-risk alternative to medication, appealing to patients looking for high safety profiles in treatment options. The company's revenue streams derive from direct consumer sales and reseller partnerships, leveraging its FDA approval and clinical validation to drive market adoption. Tivic Health Systems develops its products around non-invasive nerve stimulation technology, with ClearUP being the primary revenue-generating product. The company's strategy centers on expanding its IP portfolio to support future product development in bioelectronic medicine, particularly in vagus nerve stimulation applications. By focusing on clinical validation and doctor recommendations, Tivic Health aims to position itself as a leader in drug-free therapeutic solutions for chronic inflammatory conditions. Tivic Health Systems is one of the most popular companies on Eulerpool.

ROA Details

Understanding Tivic Health Systems's Return on Assets (ROA)

Tivic Health Systems's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.

Year-to-Year Comparison

Comparing Tivic Health Systems's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.

Impact on Investments

Investors consider Tivic Health Systems's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.

Interpreting ROA Fluctuations

Variations in Tivic Health Systems’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.

Frequently Asked Questions about Tivic Health Systems stock

Return on Assets (ROA) of Tivic Health Systems is -28.09 % in 2025.

Return on Assets (ROA) of Tivic Health Systems changed from -201.46 % to -28.09 %, representing a -86.06% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Assets (ROA) Tivic Health Systems since 2006 – with annual values, charts, and detailed analysis.

Return on Assets, also known as ROA, is a financial metric used to measure a company's profitability. It is used to determine how effectively a company uses its assets to generate profits. It is also referred to as the ratio of net income to total assets. ROA is an important indicator of a company's overall financial performance as it measures the company's ability to generate more profit from the assets it employs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Assets (ROA)'s Tivic Health Systems with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Assets (ROA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Assets (ROA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Tivic Health Systems

All Key Metrics — Tivic Health Systems